Uzbekistan
Uzbekistan
Explore linked clinical trials.11 results · Page 1 of 1
Cities
Swipe the table sideways for more columns.
| Cities | City | Country | Linked trials |
|---|---|---|---|
| Andijan | Andijan | Uzbekistan | 2 |
| Bukhara | Bukhara | Uzbekistan | 1 |
| Fergana | Fergana | Uzbekistan | 1 |
| Samarkand | Samarkand | Uzbekistan | 4 |
| Tashkent | Tashkent | Uzbekistan | 1 |
| Tashkent | Tashkent | Uzbekistan | 20 |
| Tashkent | Tashkent | Uzbekistan | 4 |
| Tashkent | Tashkent | Uzbekistan | 1 |
| Tashkent | Tashkent | Uzbekistan | 3 |
| Tashkent | Tashkent | Uzbekistan | 3 |
| Tashkent | Tashkent | Uzbekistan | 1 |
40 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Diagnostic Evaluation of Viral Persistence in Cervical Cancer | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, cervix disorder, female reproductive system disorder, female reproductive system neoplasm, neoplasm, uterine disorder | Enrolling by invitation | Not applicable | 2026-10-08 | NCT07325682 | |
| A Trial Evaluating Brelovitug (BJT-778) vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2) | Digestive System Diseases, Infections, RNA Virus Infections, hepatitis, hepatitis D virus infection, liver disorder, viral hepatitis, viral infectious disease | Recruiting | Phase 3 | 2026-10-08 | NCT07200908 | |
| EXtensive mulTilayer stEnt treatmeNt in Aortic disSectiOn | Type B Aortic Dissection | Recruiting | Not applicable | 2026-09-16 | NCT06675617 | |
| First-in-Human Study Using the SiroMax™ Sirolimus-Coated Balloon Catheter as a Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter to Treat Subjects Who Have Coronary Artery Disease (CAD) Involving In-Stent Restenosis (ISR) or an Unstented Lesion in a Small Coronary Vessel (DNSV). | Angina Pectoris, Arterial Occlusive Diseases, Chest Pain, Infarction, Necrosis, Neurologic Manifestations, Pain, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, coronary stenosis, heart disorder, ischemic disease, myocardial infarction, myocardial ischemia, vascular disorder | Recruiting | Not applicable | 2026-09-14 | NCT07811024 | |
| ColoSeal™ ICD System Safety and Feasibility Studies | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Active, not recruiting | Not applicable | 2026-09-10 | NCT06402188 | |
| Evaluation of FlowMod System While Intermittently Partially Occluding Vena Cava Blood Flow in Subjects With ADHF | Acute Decompensated Heart Failure (ADHF) | Not yet recruiting | Not applicable | 2026-09-09 | NCT07810335 | |
| Development of Methods for Effective Treatment and Improvement of Common Somatic Diseases in Children | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infections, bronchial disorder, bronchitis, cardiovascular disorder, congenital heart disease, heart disorder, lung disorder, obstructive lung disease, respiratory system disorder, respiratory tract infectious disorder | Enrolling by invitation | Early phase 1 | 2026-09-03 | NCT06267859 | |
| A Phase 1b Study of Lonitoclax + Azacitidine in Acute Myeloid Leukemia Patients | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Phase 1 | 2026-08-31 | NCT07303660 | |
| Internal Organ and Musculoskeletal Assessment in Hypothyroidism (HYPOMORPH) | Atrophy, Neurologic Manifestations, Neuromuscular Manifestations, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Sarcopenia, Signs and Symptoms, endocrine system disorder, hypothyroidism, muscular atrophy, nervous system disorder, thyroid gland disorder | Recruiting | Not stated | 2026-08-28 | NCT07707830 | |
| Anthropometric, Functional and Lifestyle Factors Associated With Testosterone Levels in Middle-Aged Men | Atrophy, Dyssomnias, Neurologic Manifestations, Neuromuscular Manifestations, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Sarcopenia, Signs and Symptoms, Sleep Disorders, Intrinsic, endocrine system disorder, eunuchism, gonadal disorder, hypogonadism, insomnia, muscular atrophy, nervous system disorder, psychiatric disorder, sleep-wake disorder | Recruiting | Not stated | 2026-08-25 | NCT07476222 | |
| A First-in-Human Study of ZE94-0605 in Patients With Advanced Solid Tumors | Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, neoplasm | Recruiting | Phase 1 | 2026-07-29 | NCT07524140 | |
| "Lumbar Operatively Inserted PerQdisc Artificial Implant Following Nulcectomy" (LOPAIN2) | Back Pain, Hernia, Intervertebral Disc Displacement, Low Back Pain, Neurologic Manifestations, Pain, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, bone disorder, intervertebral disk degenerative disorder, musculoskeletal system disorder, vertebral column disorder | Recruiting | Not applicable | 2026-07-27 | NCT05508360 | |
| A Trial Evaluating Brelovitug vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection (AZURE-4) | Digestive System Diseases, Infections, RNA Virus Infections, hepatitis, hepatitis D virus infection, liver disorder, viral hepatitis, viral infectious disease | Active, not recruiting | Phase 3 | 2026-06-29 | NCT07298330 | |
| Resoloy Initial Safety Evaluation | CLTI Defined as Rutherford Category 4 or 5; PAOD (Peripheral Arterial Obstructive Disease) | Active, not recruiting | Not applicable | 2026-06-15 | NCT07648017 | |
| Study to Assess Safety, Tolerability, PK, and PD of Multiple Doses of ZE63-0302 Administrated Orally in T2DM Patients. | Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitus | Active, not recruiting | Phase 1 | 2026-05-11 | NCT07234864 | |
| Vitamin D and Immune Response in Pulmonary Tuberculosis With and Without Chronic Pulmonary Aspergillosis | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, lung disorder, mycobacterial infectious disease, pulmonary tuberculosis, respiratory system disorder, respiratory tract infectious disorder, tuberculosis | Active, not recruiting | Not stated | 2026-04-13 | NCT07516158 | |
| Early System Experience With the Abbott Balloon-expandable TAVI System: First-In-Human Study | Ventricular Outflow Obstruction, aortic valve disorder, aortic valve stenosis, cardiovascular disorder, heart disorder, heart valve disorder | Active, not recruiting | Not applicable | 2026-04-08 | NCT07082426 | |
| SakuraBead Used as Resorbable Embolic for Genicular Artery Embolization | Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, connective tissue disorder, musculoskeletal system disorder, osteoarthritis, osteoarthritis, knee, rheumatic disorder | Active, not recruiting | Not applicable | 2026-03-18 | NCT06550024 | |
| Fibrin-Enhanced TIP Versus Grafted TIP Urethroplasty in Distal Hypospadias | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Male Urogenital Diseases, Urogenital Abnormalities, Urogenital Diseases, hypospadias, male reproductive system disorder, penile disorder | Recruiting | Not applicable | 2026-01-30 | NCT07319780 | |
| Early-stage Trial to Determine a Safe and Effective Dose for Ratutrelvir in Patients With Mild to Moderate COVID-19 | COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Recruiting | Phase 2 | 2026-01-21 | NCT07157007 | |
| Long COVID Diagnostic Reactivity Assesment Test | COVID-19, Chronic Disease, Coronaviridae Infections, Disease Attributes, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Post-Infectious Disorders, RNA Virus Infections, autonomic nervous system disorder, long COVID-19, lung disorder, nervous system disorder, pneumonia, primary dysautonomia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Enrolling by invitation | Not applicable | 2026-01-15 | NCT07343856 | |
| First-in-Human Trial of the A3-Shield System for Stabilizing Abdominal Aortic Aneurysms | Aneurysm, abdominal aortic aneurysm, aortic aneurysm, aortic disorder, cardiovascular disorder, vascular disorder | Recruiting | Not applicable | 2026-01-09 | NCT07330752 | |
| Biliary Fistulas in Surgery of Liver Echinococcosis | Biliary Fistula, Cestode infectious disease, Digestive System Diseases, Digestive System Fistula, Echinococcosis, Hepatic, Fistula, Infections, Liver Diseases, Parasitic, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, echinococcosis, helminthiasis, liver disorder, parasitic infectious disease | Recruiting | Not applicable | 2025-12-30 | NCT06612229 | |
| Presentation of Protoscolexes and Acephalocysts in the Fibrous Capsule Area of the Liver With Echinococcosis | Cestode infectious disease, Digestive System Diseases, Echinococcosis, Hepatic, Infections, Liver Diseases, Parasitic, echinococcosis, helminthiasis, liver disorder, parasitic infectious disease | Recruiting | Not stated | 2025-12-30 | NCT06316154 | |
| Verification of Risk Factors of Thrombohemorrhagic Complications in Recipients After Related Liver Transplantation | Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cirrhosis of liver, liver disorder | Recruiting | Not stated | 2025-12-30 | NCT06169592 |